POINT Biopharma Announces Closing of Public Offering of 13,900,000 Shares of Common Stock

September 16, 2022

https://www.globenewswire.com/news-release/2022/09/16/2517842/0/en/POINT-Biopharma-Announces-Closing-of-Public-Offering-of-13-900-000-Shares-of-Common-Stock.html

INDIANAPOLIS, Sept. 16, 2022 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (NASDAQ:PNT) (the “Company” or “POINT”), a company accelerating the discovery, development and global access to life-changing radiopharmaceuticals, today announced the closing of its previously announced underwritten public offering of 13,900,000 shares of Common Stock at a public offering price of $9.00 per share. The gross proceeds to the Company from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, were approximately $125 million.

Read more at globenewswire.com

Related news for (PNT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.